Mini Review
Published on 19 Aug 2022
Bioactive natural products in COVID-19 therapy
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.926507
- 10,481 views
- 68 citations
11 articles related to "Covid 19 Therapy"
Articles
Editorial
Published on 24 Aug 2021
Editorial: Drug Repurposing for COVID-19 Therapy
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.748886
- 3,022 views
- 5 citations
Original Research
Published on 02 Feb 2023
Identifying potential pharmacological targets and molecular pathways of Meliae cortex for COVID-19 therapy
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1128164
- 4,766 views
- 5 citations
Mini Review
Published on 12 Apr 2022
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.899633
- 10,918 views
- 49 citations
Original Research
Published on 25 Jan 2023
Fireworks explosion boosted Harris Hawks optimization for numerical optimization: Case of classifying the severity of COVID-19
Frontiers in Neuroinformatics
doi 10.3389/fninf.2022.1055241
- 7,467 views
- 1 citation
Review
Published on 17 Feb 2023
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1127358
- 8,001 views
- 28 citations
Original Research
Published on 06 Sep 2022
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.984098
- 5,201 views
- 17 citations
Original Research
Published on 24 Jan 2022
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.830527
- 19,982 views
- 242 citations
Original Research
Published on 27 Feb 2024
Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19
in Infectious Diseases: Pathogenesis and Therapy
Frontiers in Medicine
doi 10.3389/fmed.2024.1319980
- 3,307 views
- 7 citations
Systematic Review
Published on 29 Aug 2022
Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.923286
- 4,801 views
- 9 citations
Correction
Published on 08 May 2024
Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1422261
- 1,346 views
- 1 citation